Your browser doesn't support javascript.
loading
On-Chip Preconcentration Microchip Capillary Electrophoresis Based CE-PRM-LIVE for High-Throughput Selectivity Profiling of Deubiquitinase Inhibitors.
Zhu, He; Mellors, J Scott; Chan, Wai Cheung; Thompson, J Will; Ficarro, Scott B; Tavares, Isidoro; Bratt, Ariana S; Decker, Jens; Krause, Michael; Kruppa, Gary; Buhrlage, Sara J; Marto, Jarrod A.
Affiliation
  • Zhu H; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, United States.
  • Mellors JS; 908 Devices Inc., Boston, Massachusetts 02210, United States.
  • Chan WC; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, United States.
  • Thompson JW; 908 Devices Inc., Boston, Massachusetts 02210, United States.
  • Ficarro SB; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, United States.
  • Tavares I; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, United States.
  • Bratt AS; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, United States.
  • Decker J; Bruker Daltonics GmbH & Co. KG, Bremen 28359, Germany.
  • Krause M; Bruker Daltonics GmbH & Co. KG, Bremen 28359, Germany.
  • Kruppa G; Bruker S.R.O., District Brno-City 61900 Czech Republic.
  • Buhrlage SJ; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, United States.
  • Marto JA; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, United States.
Anal Chem ; 94(27): 9508-9513, 2022 07 12.
Article in En | MEDLINE | ID: mdl-35729701
The family of deubiquitinases (DUBs) comprises ∼100 enzymes that cleave ubiquitin from substrate proteins and thereby regulate key aspects of human physiology. DUBs have recently emerged as disease-relevant and chemically tractable, although currently there are no approved DUB-targeting drugs and most preclinical small molecules are low-potency and/or multitargeted. We paired a novel capillary electrophoresis microchip containing an integrated, "on-chip" C18 bed (SPE-ZipChip) with a TMT version of our recently described PRM-LIVE acquisition scheme on a timsTOF Pro mass spectrometer to facilitate rapid activity-based protein profiling of DUB inhibitors. We demonstrate the ability of the SPE-ZipChip to improve proteome coverage of complex samples as well as the quantitation integrity of CE-PRM-LIVE for TMT labeled samples. These technologies provide a platform to accurately quantify competitive binding of covalent and reversible inhibitors in a multiplexed assay that spans 49 endogenous DUBs in less than 15 min.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ubiquitin / Electrophoresis, Microchip Limits: Humans Language: En Journal: Anal Chem Year: 2022 Type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ubiquitin / Electrophoresis, Microchip Limits: Humans Language: En Journal: Anal Chem Year: 2022 Type: Article Affiliation country: United States